So. I’ve had some time to digest the PR and aside from
So. I’ve had some time to digest the PR and aside from what Beasley pointed out about everything being complete and yet for some reason they could not say or chose not to say that the IND submission was imminent. That is a glaring error or shortcoming depending on the details.
I was pleasantly surprised that anything was done regarding AZ. There has not been a form effect posted yet so they are still in quiet period but Joe seems willing to talk about NGIO/NUGX. Maybe the form effect is on the way.
I don’t like this being posted 5 weeks out. The last time that was a disaster. But I do understand that if Joe didn’t address the GMP production yesterday the speculation would have been that they missed another target date. I also understand him wanting to wait until after May 1 so he can talk about AZ being finished. Hopefully the IND will be submitted and the form effect will be posted and listing / up list will be in process. I’d also like to know if/when the share bonuses will be paid. Would be nice if the company bought the shares at market price rather than dilute us with treasury shares.
I would certainly expect PRs on most of these topics leading up to the CC.
2
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Visual Comfort & Co. Unveils Its Stunning New Showroom Visual Comfort & Co. has proudly announced the launch of its latest showroom, covering an impressive 4,000 square feet. This destination not only features the visionary work of renowned designers but also creates a welcoming environment for customers looking to enhance their spaces with stylish lighting. Designer...
Continue Reading
Event Highlights and Community Impact Event Showcases Innovation, Community, and the Power of Women Entrepreneurs NEW YORK / -- The Enthuse Foundation, a non-profit organization dedicated to empowering a new generation of women entrepreneurs, hosted its 7th Annual Women Founders Pitch Competition recently at The Town Hall by Skylight in the bustling Penn District of New...
Continue Reading
JPMorgan's CEO Expresses Market Anxiety Jamie Dimon, the CEO of JPMorgan Chase & Co. (NYSE:JPM), is voicing serious concerns about the potential for a stock market crash, suggesting that the likelihood is significantly underestimated. During a candid interview, he expressed that he is 'far more worried than others' about the chances of a major market correction....
Continue Reading
Market Prepares for the Impact of the CPI Report This Wednesday, the market is bracing for significant updates, with index futures reflecting a cautious stance. Investors are eagerly anticipating the consumer price index (CPI) data, which could have serious implications for market trends. A recent presidential debate between two prominent candidates has caught the...
Continue Reading
Understanding the Class Action Lawsuit Against Cassava Sciences Investors holding shares in Cassava Sciences, Inc. find themselves at an important juncture as recent developments unfold regarding class action lawsuits against the company. If you are one of the investors who purchased securities of Cassava Sciences, it is crucial to be aware of the impending deadlines to...
Continue Reading